Prisma Health-Upstate
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Prisma Health-Upstate sits in the top decile of US sponsors by registered trial count (#312 of 15,742 sponsors by registered trial count).
Prisma Health-Upstate: 67 sponsored US clinical trials, 6 recruiting.
Prisma Health-Upstate sponsors 67 registered US clinical trials on ClinicalTrials.gov, 6 of them currently recruiting, and 50 completed. 10 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cancer, with 3 trials.
Top-decile sponsor footprint
Prisma Health-Upstate ranks in the top decile of sponsors by registered trial count (#312 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
50 of 58 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
67 total, page 2 of 2
Patient-Centered Models of HCV Care for People Who Inject Drugs
NCT02824640
Wound Vac Polypropylene Suture Pilot Study
NCT02929238
Evaluating the Effects of Acupuncture in the Treatment of Taxane Induces Peripheral Neuropathy
NCT02831114
Laparoscopic Cholecystectomy Care Protocol
NCT04269096
Mindfulness Intervention to Improve Symptomology Among Cancer Survivors; Focus on Sleep and Stress Improvement
NCT02633748
Use of Heart Rate Variability (HRV) Biofeedback for Cancer Survivors
NCT03692624
Effects of Upper Extremity Immobilization and Use of a Steering Wheel Spinner Knob Following Distal Radius Fracture
NCT02105038
Intensive Models of HCV Care for Injection Drug Users
NCT01857245
Immobilization Versus Observation in Children With Toddler's Fractures: a Prospective Randomized Controlled Trial
NCT01926795
Diabetic Foot Infection Antibiotic Study
NCT01539811
Use of Probiotics to Aid in Weight Loss
NCT01445704
Early Versus Delayed Skin Staple Removal Following Cesarean Delivery in the Obese Patient
NCT01114451
Fluid Lavage of Open Wounds
NCT00788398
Trial of Melaxin Cancer Vaccine Plus Bacillus Calmette-Guerin (BCG) to Treat Malignant Melanoma
NCT00671554
Use of Continuous Passive Motion in the Post-Operative Treatment of Intra-articular Knee Fractures
NCT00591929
Standard Reaming Versus Reaming/Irrigating/Aspirating for Intramedullary Nailing of Femoral Shaft Fractures
NCT00534326
Non-Operative Versus Operative Treatment for High-Energy Midshaft Clavicle Fractures
NCT00590850
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 5 |
| Phase 3 | 2 |
| Phase 4 | 8 |
Therapeutic Areas
What is open in the Prisma Health-Upstate pipeline
6 recruiting of 67 indexed (9% open); 50 completed (75%).
Phase mix: 10 late (III/IV) vs 7 early (I/II) (balanced across stages).
Top condition: Cancer (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Prisma Health-Upstate: open-pipeline peers nationwide
Peers matched on 67 registered trials and 9% open enrollment, not the therapeutic-area sidebar.
Prisma Health-Upstate sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 67 trials (± recruiting share)
- University at Buffalo · 67 trials · 0% recruiting
- Vanda Pharmaceuticals · 68 trials · 22% recruiting
- Alkermes · 66 trials · 9% recruiting
- Cornell University · 66 trials · 15% recruiting
Sponsors near 9% open enrollment (± trial volume)
- Grifols Therapeutics · 9% recruiting · 34 trials
- DBV Technologies · 9% recruiting · 11 trials
- Florida Gulf Coast University · 9% recruiting · 11 trials
- Genfit · 9% recruiting · 11 trials
Related
What to do with this Prisma Health-Upstate page
67 registered trials is a research-attention snapshot, not an endorsement of Prisma Health-Upstate or any single study.
- 6 of Prisma Health-Upstate's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cancer is the condition Prisma Health-Upstate studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Prisma Health-Upstate pipeline card: 67 registered trials from official public datasets.Report a data error.